Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- Characterize the safety and tolerability of IMGN529 in combination with rituximab when administered IV every three weeks to adult patients with relapsed and/or refractory NHL - Determine the anti-tumor activity of IMGN529 in combination with rituximab when administered IV every three weeks to adult patients with relapsed and/or refractory NHL
Inclusion criteria
- Patients with Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma and Other Forms of Non-Hodgkin’s Lymphoma